vs

Side-by-side financial comparison of GERON CORP (GERN) and InvenTrust Properties Corp. (IVT). Click either name above to swap in a different company.

InvenTrust Properties Corp. is the larger business by last-quarter revenue ($77.4M vs $47.2M, roughly 1.6× GERON CORP). InvenTrust Properties Corp. runs the higher net margin — 3.4% vs -39.0%, a 42.5% gap on every dollar of revenue. On growth, GERON CORP posted the faster year-over-year revenue change (67.1% vs 8.6%). Over the past eight quarters, GERON CORP's revenue compounded faster (1597.0% CAGR vs 7.6%).

Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.

InvenTrust Properties Corp. is a real estate investment trust that invests in shopping malls. As of December 31, 2024, the company owned interests in 68 properties comprising 11.0 million square feet.

GERN vs IVT — Head-to-Head

Bigger by revenue
IVT
IVT
1.6× larger
IVT
$77.4M
$47.2M
GERN
Growing faster (revenue YoY)
GERN
GERN
+58.4% gap
GERN
67.1%
8.6%
IVT
Higher net margin
IVT
IVT
42.5% more per $
IVT
3.4%
-39.0%
GERN
Faster 2-yr revenue CAGR
GERN
GERN
Annualised
GERN
1597.0%
7.6%
IVT

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
GERN
GERN
IVT
IVT
Revenue
$47.2M
$77.4M
Net Profit
$-18.4M
$2.7M
Gross Margin
Operating Margin
-29.4%
-11.0%
Net Margin
-39.0%
3.4%
Revenue YoY
67.1%
8.6%
Net Profit YoY
30.3%
-72.8%
EPS (diluted)
$-0.03
$0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GERN
GERN
IVT
IVT
Q4 25
$77.4M
Q3 25
$47.2M
$74.5M
Q2 25
$49.0M
$73.6M
Q1 25
$39.6M
$73.8M
Q4 24
$71.2M
Q3 24
$28.3M
$68.5M
Q2 24
$882.0K
$67.4M
Q1 24
$304.0K
$66.8M
Net Profit
GERN
GERN
IVT
IVT
Q4 25
$2.7M
Q3 25
$-18.4M
$6.0M
Q2 25
$-16.4M
$95.9M
Q1 25
$-19.8M
$6.8M
Q4 24
$9.8M
Q3 24
$-26.4M
$-539.0K
Q2 24
$-67.4M
$1.5M
Q1 24
$-55.4M
$2.9M
Operating Margin
GERN
GERN
IVT
IVT
Q4 25
-11.0%
Q3 25
-29.4%
-9.8%
Q2 25
-25.4%
Q1 25
-42.2%
-10.5%
Q4 24
-3.6%
Q3 24
-99.8%
-18.7%
Q2 24
-7860.9%
-13.6%
Q1 24
-18465.1%
-13.1%
Net Margin
GERN
GERN
IVT
IVT
Q4 25
3.4%
Q3 25
-39.0%
8.1%
Q2 25
-33.4%
130.4%
Q1 25
-50.1%
9.2%
Q4 24
13.8%
Q3 24
-93.5%
-0.8%
Q2 24
-7639.8%
2.2%
Q1 24
-18220.4%
4.3%
EPS (diluted)
GERN
GERN
IVT
IVT
Q4 25
$0.02
Q3 25
$-0.03
$0.08
Q2 25
$-0.02
$1.23
Q1 25
$-0.03
$0.09
Q4 24
$0.14
Q3 24
$-0.04
$-0.01
Q2 24
$-0.10
$0.02
Q1 24
$-0.09
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GERN
GERN
IVT
IVT
Cash + ST InvestmentsLiquidity on hand
$78.1M
Total DebtLower is stronger
$825.9M
Stockholders' EquityBook value
$248.7M
$1.8B
Total Assets
$567.4M
$2.8B
Debt / EquityLower = less leverage
0.46×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GERN
GERN
IVT
IVT
Q4 25
Q3 25
$78.1M
Q2 25
$77.7M
Q1 25
$83.7M
Q4 24
Q3 24
$60.3M
Q2 24
$116.9M
Q1 24
$189.8M
Total Debt
GERN
GERN
IVT
IVT
Q4 25
$825.9M
Q3 25
$764.6M
Q2 25
$746.3M
Q1 25
$740.7M
Q4 24
$740.4M
Q3 24
$740.1M
Q2 24
$812.2M
Q1 24
$827.5M
Stockholders' Equity
GERN
GERN
IVT
IVT
Q4 25
$1.8B
Q3 25
$248.7M
$1.8B
Q2 25
$259.5M
$1.8B
Q1 25
$268.2M
$1.7B
Q4 24
$1.8B
Q3 24
$292.3M
$1.8B
Q2 24
$306.7M
$1.5B
Q1 24
$344.9M
$1.5B
Total Assets
GERN
GERN
IVT
IVT
Q4 25
$2.8B
Q3 25
$567.4M
$2.7B
Q2 25
$555.2M
$2.7B
Q1 25
$562.5M
$2.6B
Q4 24
$2.6B
Q3 24
$444.9M
$2.6B
Q2 24
$449.4M
$2.5B
Q1 24
$482.1M
$2.5B
Debt / Equity
GERN
GERN
IVT
IVT
Q4 25
0.46×
Q3 25
0.42×
Q2 25
0.41×
Q1 25
0.42×
Q4 24
0.42×
Q3 24
0.42×
Q2 24
0.53×
Q1 24
0.53×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GERN
GERN
IVT
IVT
Operating Cash FlowLast quarter
$-13.6M
$155.4M
Free Cash FlowOCF − Capex
$110.9M
FCF MarginFCF / Revenue
143.3%
Capex IntensityCapex / Revenue
57.5%
Cash ConversionOCF / Net Profit
58.41×
TTM Free Cash FlowTrailing 4 quarters
$193.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GERN
GERN
IVT
IVT
Q4 25
$155.4M
Q3 25
$-13.6M
$43.8M
Q2 25
$-27.4M
$48.7M
Q1 25
$-48.0M
$20.2M
Q4 24
$136.9M
Q3 24
$-58.9M
$38.4M
Q2 24
$-53.5M
$46.7M
Q1 24
$-62.3M
$14.8M
Free Cash Flow
GERN
GERN
IVT
IVT
Q4 25
$110.9M
Q3 25
$31.4M
Q2 25
$38.0M
Q1 25
$12.8M
Q4 24
$100.8M
Q3 24
$29.3M
Q2 24
$-53.7M
$37.2M
Q1 24
$-62.9M
$7.7M
FCF Margin
GERN
GERN
IVT
IVT
Q4 25
143.3%
Q3 25
42.2%
Q2 25
51.6%
Q1 25
17.4%
Q4 24
141.5%
Q3 24
42.8%
Q2 24
-6086.6%
55.2%
Q1 24
-20680.3%
11.5%
Capex Intensity
GERN
GERN
IVT
IVT
Q4 25
57.5%
Q3 25
16.7%
Q2 25
14.6%
Q1 25
10.0%
Q4 24
50.7%
Q3 24
0.0%
13.3%
Q2 24
23.4%
14.0%
Q1 24
202.3%
10.6%
Cash Conversion
GERN
GERN
IVT
IVT
Q4 25
58.41×
Q3 25
7.27×
Q2 25
0.51×
Q1 25
2.97×
Q4 24
13.97×
Q3 24
Q2 24
31.15×
Q1 24
5.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons